ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,271Medicare Part D Prescriptions Filled, Including Refills

Rank: 528 out of 2170

$403K Total Retail Price of All Prescriptions

Rank: 660 out of 2170

282 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 282 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 4,597 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 314 164 1 2
AMLODIPINE BESYLATE 308 223 2 4
QUINAPRIL HCL 255 172 3 117
FUROSEMIDE 250 161 4 6
LEVOTHYROXINE SODIUM 196 122 5 5
HYDROCHLOROTHIAZIDE 180 123 6 9
ATENOLOL 165 126 7 23
ALENDRONATE SODIUM 155 105 8 36
GABAPENTIN 149 98 9 14
METFORMIN HCL 148 73 10 8
SERTRALINE HCL 146 78 11 25
SIMVASTATIN 145 93 12 1
ATORVASTATIN CALCIUM 137 82 13 12
MELOXICAM 137 58 13 28
SPIRIVA 136 69 15 49
HYDROCODONE-ACETAMINOPHEN 135 32 S3 16 7
GLIPIZIDE XL 131 90 17 81
LOVASTATIN 130 107 18 34
METOPROLOL SUCCINATE 127 62 19 13
PROAIR HFA 117 59 20 43
TRAMADOL HCL 115 37 21 18
RANITIDINE HCL 113 65 22 40
ENALAPRIL MALEATE 110 72 23 64
METFORMIN HCL ER 109 53 24 35
POTASSIUM CHLORIDE 105 89 25 16
PRAVASTATIN SODIUM 98 51 26 11
TRAZODONE HCL 86 45 27 38
LIPITOR 85 50 28 83
OXYCODONE-ACETAMINOPHEN 82 19 S2 29 60
CITALOPRAM HBR 79 69 30 19
LOSARTAN POTASSIUM 73 47 31 21
WARFARIN SODIUM 72 35 32 15
NEXIUM 70 30 33 22
POLYETHYLENE GLYCOL 3350 69 62 34 63
METOPROLOL TARTRATE 66 22 35 10
TRIAMTERENE-HCTZ 65 59 36 66
ACTOS 64 37 37 108
FLUTICASONE PROPIONATE 63 45 38 30
AMITRIPTYLINE HCL 61 37 R 39 61
LISINOPRIL 60 11 40 3
ADVAIR DISKUS 59 22 41 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 34 41 20
FELODIPINE ER 57 35 43 193
ISOSORBIDE MONONITRATE ER 56 50 44 50
BENAZEPRIL HCL 54 33 45 55
PAROXETINE HCL 53 22 46 65
CRESTOR 52 26 47 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.